{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:37:51Z","timestamp":1793147871540,"version":"4.5.0"},"reference-count":182,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["19L2065"],"award-info":[{"award-number":["19L2065"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.intimp.2022.108870","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T02:11:49Z","timestamp":1652753509000},"page":"108870","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["BCG Vaccination: A potential tool against COVID-19 and COVID-19-like Black Swan incidents"],"prefix":"10.1016","volume":"108","author":[{"given":"Wenping","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqing","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2022.108870_b0005","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2021.36.e124","article-title":"Will Mutations in the Spike Protein of SARS-CoV-2 Lead to the Failure of COVID-19 Vaccines?","volume":"36","author":"Jia","year":"2021","journal-title":"J. Korean Med. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2022.108870_b0010","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1037\/fsh0000486","article-title":"COVID-19: Complexity and the Black Swan","volume":"38","author":"Valeras","year":"2020","journal-title":"Families Syst. Health"},{"issue":"1","key":"10.1016\/j.intimp.2022.108870_b0015","article-title":"Dynamic Changes in Chest CT Images Over 167 Days in 11 Patients with COVID-19","volume":"1","author":"Liang","year":"2021","journal-title":"A Case Ser. Literature Rev. Zoonoses"},{"issue":"7","key":"10.1016\/j.intimp.2022.108870_b0020","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1080\/14760584.2021.1938550","article-title":"COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials","volume":"20","author":"Gong","year":"2021","journal-title":"Expert Rev. Vaccines"},{"issue":"2","key":"10.1016\/j.intimp.2022.108870_b0025","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/08830185.2021.1922685","article-title":"Tuberculosis vaccine BCG: the magical effect of the old vaccine in the fight against the COVID-19 pandemic","volume":"41","author":"Aspatwar","year":"2022","journal-title":"Int. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.108870_b0030","doi-asserted-by":"crossref","DOI":"10.15212\/ZOONOSES-2021-0009","article-title":"SARS-CoV-2 Lambda Variant: Spatiotemporal Distribution and Potential Public Health Impact","volume":"1","author":"Chen","year":"2021","journal-title":"Zoonoses."},{"issue":"1","key":"10.1016\/j.intimp.2022.108870_b0035","doi-asserted-by":"crossref","DOI":"10.15212\/ZOONOSES-2021-1003","article-title":"Variants of SARS Coronavirus-2 and Their Potential Impact on the Future of the COVID-19 Pandemic","volume":"1","author":"Li","year":"2021","journal-title":"Zoonoses."},{"issue":"1","key":"10.1016\/j.intimp.2022.108870_b0040","doi-asserted-by":"crossref","DOI":"10.15212\/ZOONOSES-2021-0005","article-title":"Rapid Global Spread of the SARS-CoV-2 Delta (B.1.617.2) Variant: Spatiotemporal Variation and Public Health Impact","volume":"1","author":"Shi","year":"2021","journal-title":"Zoonoses."},{"issue":"1","key":"10.1016\/j.intimp.2022.108870_b0045","doi-asserted-by":"crossref","DOI":"10.15212\/ZOONOSES-2022-0001","article-title":"SARS-CoV-2 Variants and Vaccination","volume":"2","author":"Liu","year":"2021","journal-title":"Zoonoses."},{"key":"10.1016\/j.intimp.2022.108870_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2021.04.006","article-title":"mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant","author":"Garcia-Beltran","year":"2021","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.intimp.2022.108870_b0055","doi-asserted-by":"crossref","DOI":"10.15212\/ZOONOSES-2021-0024","article-title":"Genome Characterization and Potential Risk Assessment of the Novel SARS-CoV-2 Variant Omicron (B.1.1.529)","volume":"1","author":"Qin","year":"2021","journal-title":"Zoonoses."},{"issue":"6","key":"10.1016\/j.intimp.2022.108870_b0060","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1080\/21645515.2020.1833577","article-title":"Harnessing the non-specific immunogenic effects of available vaccines to combat COVID-19","volume":"17","author":"Mosaddeghi","year":"2021","journal-title":"Hum Vaccin Immunother."},{"issue":"9","key":"10.1016\/j.intimp.2022.108870_b0065","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1080\/14760584.2021.1960161","article-title":"Repurposing of the childhood vaccines: could we train the immune system against the SARS-CoV-2","volume":"20","author":"Sharma","year":"2021","journal-title":"Expert Rev. Vaccines."},{"issue":"3","key":"10.1016\/j.intimp.2022.108870_b0070","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ijtb.2020.10.012","article-title":"Is the tuberculosis vaccine BCG an alternative weapon for developing countries to defeat COVID-19?","volume":"68","author":"Gong","year":"2021","journal-title":"Indian J Tuberc."},{"issue":"6","key":"10.1016\/j.intimp.2022.108870_b0075","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.amjms.2021.03.003","article-title":"Bacillus Calmette-Guerin Vaccine and Nonspecific Immunity","volume":"361","author":"Parmar","year":"2021","journal-title":"Am. J. Medical Sci."},{"issue":"34","key":"10.1016\/j.intimp.2022.108870_b0080","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1016\/j.vaccine.2016.06.020","article-title":"Heterologous vaccine effects","volume":"34","author":"Saadatian-Elahi","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2022.108870_b0085","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin. Infectious Dis.: An Official Publication Infect. Diseases Soc. Am."},{"issue":"2","key":"10.1016\/j.intimp.2022.108870_b0090","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.clinthera.2013.01.007","article-title":"Nonspecific effects of vaccines and the reduction of mortality in children","volume":"35","author":"Shann","year":"2013","journal-title":"Clin. Ther."},{"issue":"21-22","key":"10.1016\/j.intimp.2022.108870_b0095","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1016\/S0264-410X(03)00181-6","article-title":"BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A non-specific beneficial effect of BCG?","volume":"21","author":"Garly","year":"2003","journal-title":"Vaccine."},{"key":"10.1016\/j.intimp.2022.108870_b0100","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/ije\/dyh392","article-title":"BCG vaccination scar associated with better childhood survival in Guinea-Bissau","volume":"34","author":"Roth","year":"2005","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.intimp.2022.108870_b0105","first-page":"1435","article-title":"Routine vaccinations and child survival: follow up study in Guinea-Bissau","volume":"321","author":"Kristensen","year":"2000","journal-title":"West Africa. Bmj."},{"key":"10.1016\/j.intimp.2022.108870_b0110","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/infdis\/jir240","article-title":"Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period?","volume":"204","author":"Aaby","year":"2011","journal-title":"J. Infectious Dis."},{"issue":"3","key":"10.1016\/j.intimp.2022.108870_b0115","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/INF.0b013e3182458289","article-title":"Small randomized trial among low-birth-weight children receiving bacillus Calmette-Gu\u00e9rin vaccination at first health center contact","volume":"31","author":"Biering-S\u00f8rensen","year":"2012","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"12","key":"10.1016\/j.intimp.2022.108870_b0120","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.cmi.2019.04.020","article-title":"Non-specific effects of BCG vaccine on viral infections","volume":"25","author":"Moorlag","year":"2019","journal-title":"Clin. Microbiol. Infection: The Official Publication Eur. Soc. Clin. Microbiol. Infectious Dis."},{"key":"10.1016\/j.intimp.2022.108870_b0125","article-title":"Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review","volume":"355","author":"Higgins","year":"2016","journal-title":"Bmj."},{"issue":"1","key":"10.1016\/j.intimp.2022.108870_b0130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.intimp.2022.108870_b0135","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1093\/infdis\/jiv332","article-title":"BCG vaccination enhances the immunogenicity of subsequent influenza vaccination in healthy volunteers: a randomized, placebo-controlled pilot study","volume":"212","author":"Leentjens","year":"2015","journal-title":"J. Infectious Dis."},{"issue":"2","key":"10.1016\/j.intimp.2022.108870_b0140","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1128\/AAC.27.2.203","article-title":"Ineffectiveness and toxicity of BCG vaccine for the prevention of recurrent genital herpes","volume":"27","author":"Douglas","year":"1985","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.intimp.2022.108870_b0145","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1525-1470.2012.01848.x","article-title":"Treatment of common and plane warts in children with topical viable Bacillus Calmette-Guerin","volume":"30","author":"Salem","year":"2013","journal-title":"Pediatr. Dermatol."},{"key":"10.1016\/j.intimp.2022.108870_b0150","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2478\/folmed-2013-0005","article-title":"Immunomodulatory effects of BCG in patients with recurrent respiratory papillomatosis","volume":"55","author":"Vetskova","year":"2013","journal-title":"Folia Med (Plovdiv)."},{"issue":"3","key":"10.1016\/j.intimp.2022.108870_b0155","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4103\/0378-6323.193623","volume":"83","author":"Podder","year":"2017","journal-title":"Indian J. Dermatol. Venereol. leprol."},{"issue":"3","key":"10.1016\/j.intimp.2022.108870_b0160","doi-asserted-by":"crossref","first-page":"330","DOI":"10.18295\/squmj.2020.20.03.013","article-title":"The Bacillus Calmette-Gu\u00e9rin (BCG) Vaccine: Is it a better choice for the treatment of viral warts?","volume":"20","author":"Al-Yassen","year":"2020","journal-title":"Sultan Qaboos Univ. Medical J."},{"issue":"10","key":"10.1016\/j.intimp.2022.108870_b0165","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.vaccine.2004.09.006","article-title":"Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls: Community based case\u2013control study","volume":"23","author":"Stensballe","year":"2005","journal-title":"Vaccine."},{"key":"10.1016\/j.intimp.2022.108870_b0170","first-page":"185","article-title":"The efficacy of Bacillus Calmette-Guerin vaccinations for the prevention of acute upper respiratory tract infection in the elderly","volume":"43","author":"Wardhana","year":"2011","journal-title":"Acta medica Indonesiana."},{"issue":"2","key":"10.1016\/j.intimp.2022.108870_b0175","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cell.2020.08.051","article-title":"Activate: Randomized Clinical Trial of BCG Vaccination against Infection in the Elderly","volume":"183","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.intimp.2022.108870_b0180","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S1473-3099(20)30994-4","article-title":"The effect of BCG revaccination on all-cause mortality beyond infancy: 30-year follow-up of a population-based, double-blind, randomised placebo-controlled trial in Malawi","volume":"21","author":"Glynn","year":"2021","journal-title":"Lancet. Infect. Dis"},{"issue":"2","key":"10.1016\/j.intimp.2022.108870_b0185","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.urology.2004.09.025","article-title":"Application of viable bacille Calmette-Gu\u00e9rin topically as a potential therapeutic modality in condylomata acuminata: a placebo-controlled study","volume":"65","author":"Metawea","year":"2005","journal-title":"Urology."},{"issue":"5","key":"10.1016\/j.intimp.2022.108870_b0190","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J. Urol."},{"key":"10.1016\/j.intimp.2022.108870_b0195","article-title":"Bladder Cancer Immunotherapy by BCG Is Associated with a Significantly Reduced Risk of Alzheimer's Disease and Parkinson's Disease","volume":"9","author":"Klinger","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"9","key":"10.1016\/j.intimp.2022.108870_b0200","doi-asserted-by":"crossref","first-page":"e1912014","DOI":"10.1001\/jamanetworkopen.2019.12014","article-title":"Association of BCG Vaccination in Childhood With Subsequent Cancer Diagnoses: A 60-Year Follow-up of a Clinical Trial","volume":"2","author":"Usher","year":"2019","journal-title":"JAMA network open."},{"issue":"5","key":"10.1016\/j.intimp.2022.108870_b0205","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/joim.12965","article-title":"Association between Bacillus Calmette-Gu\u00e9rin vaccination and lymphoma: a population-based birth cohort study","volume":"286","author":"Salmon","year":"2019","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.intimp.2022.108870_b0210","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/jnci\/60.4.785","article-title":"Efficacy of BCG vaccination in prevention of cancer: an update","volume":"60","author":"Snider","year":"1978","journal-title":"J. Natl Cancer Inst."},{"issue":"1","key":"10.1016\/j.intimp.2022.108870_b0215","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-018-0062-8","article-title":"Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations","volume":"3","author":"K\u00fchtreiber","year":"2018","journal-title":"npj Vaccines"},{"issue":"8","key":"10.1016\/j.intimp.2022.108870_b0220","doi-asserted-by":"crossref","first-page":"e41756","DOI":"10.1371\/journal.pone.0041756","article-title":"Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes","volume":"7","author":"Faustman","year":"2012","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.intimp.2022.108870_b0225","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s10096-020-03813-y","article-title":"Differential effects of BCG vaccine on immune responses induced by vi polysaccharide typhoid fever vaccination: an explorative randomized trial","volume":"39","author":"Blok","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.intimp.2022.108870_b0230","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/infdis\/136.2.171","article-title":"Nonspecific protection of mice against influenza virus infection by local or systemic immunization with Bacille Calmette-Gu\u00e9rin","volume":"136","author":"Spencer","year":"1977","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.intimp.2022.108870_b0235","doi-asserted-by":"crossref","first-page":"e0180143","DOI":"10.1371\/journal.pone.0180143","article-title":"Boosting efferocytosis in alveolar space using BCG vaccine to protect host against influenza pneumonia","volume":"12","author":"Mukherjee","year":"2017","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.intimp.2022.108870_b0240","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0166-3542(85)90025-7","article-title":"Enhancement of non-specific resistance to viral infection by muramyldipeptide and its analogs","volume":"5","author":"Ikeda","year":"1985","journal-title":"Antiviral Res."},{"key":"10.1016\/j.intimp.2022.108870_b0245","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0264-410X(87)90155-1","article-title":"Suppression of Sendai virus growth by treatment with N alpha-acetylmuramyl-L-alanyl-D-isoglutaminyl-N epsilon-stearoyl-L-lysine in mice","volume":"5","author":"Ishihara","year":"1987","journal-title":"Vaccine."},{"key":"10.1016\/j.intimp.2022.108870_b0250","first-page":"173","article-title":"Increased resistance to virus infections of mice inoculated with BCG (Bacillus calmette-gu\u00e9rin)","volume":"127","author":"Floc'h","year":"1976","journal-title":"Annales d'immunologie."},{"key":"10.1016\/j.intimp.2022.108870_b0255","doi-asserted-by":"crossref","unstructured":"S.E. Starr, A.M. Visintine, M.O. Tomeh, A.J. Nahmias, Effects of immunostimulants on resistance of newborn mice to herpes simplex type 2 infection. Proceedings of the Society for Experimental Biology and Medicine Society for Experimental Biology and Medicine (New York, NY). 1976;152:57-60.","DOI":"10.3181\/00379727-152-39327"},{"issue":"5-6","key":"10.1016\/j.intimp.2022.108870_b0260","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000452171","article-title":"Bacillus Calmette-Gu\u00e9rin Confers Neuroprotection in a Murine Model of Japanese Encephalitis","volume":"23","author":"Kulkarni","year":"2016","journal-title":"NeuroImmunoModulation"},{"issue":"1","key":"10.1016\/j.intimp.2022.108870_b0265","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1128\/iai.19.1.225-230.1978","article-title":"Enhanced resistance against encephalomyocarditis virus infection in mice, induced by a nonviable Mycobacterium tuberculosis oil-droplet vaccine","volume":"19","author":"Lodmell","year":"1978","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.intimp.2022.108870_b0270","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1128\/iai.22.3.740-745.1978","article-title":"Induction of enhanced resistance against encephalomyocarditis virus infection of mice by nonviable Mycobacterium tuberculosis: mechanisms of protection","volume":"22","author":"Lodmell","year":"1978","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.intimp.2022.108870_b0275","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1128\/iai.20.1.312-314.1978","article-title":"Effect of Mycobacterium tuberculosis BCG infection on the resistance of mice to ectromelia virus infection: participation of interferon in enhanced resistance","volume":"20","author":"Suenaga","year":"1978","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.intimp.2022.108870_b0280","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1128\/iai.42.2.567-573.1983","article-title":"Mechanisms of enhanced resistance of Mycobacterium bovis BCG-treated mice to ectromelia virus infection","volume":"42","author":"Sakuma","year":"1983","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.intimp.2022.108870_b0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/jb.92.1.1-5.1966","article-title":"Stimulation of nonspecific resistance to infection by a crude cell wall preparation from Mycobacterium phlei","volume":"92","author":"Fox","year":"1966","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.intimp.2022.108870_b0290","first-page":"53","article-title":"Studies on the heterologous immunogenicity of a menthanol-insoluble fraction of attenuated tubercle bacilli (BCG)","volume":"119","author":"Weiss","year":"1964","journal-title":"I. Antimicrobial Protection. J. Exp Med."},{"key":"10.1016\/j.intimp.2022.108870_b0295","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3412\/jsb.21.675","article-title":"Non-specific resistance of the BCG vaccinated mice to the infection with Salmonella enteritidis (I)","volume":"21","author":"Ujiie","year":"1966","journal-title":"Nihon Saikingaku Zasshi."},{"key":"10.1016\/j.intimp.2022.108870_b0300","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/cid\/civ144","article-title":"Nonspecific (heterologous) protection of neonatal bcg vaccination against hospitalization due to respiratory infection and sepsis","volume":"60","author":"de Castro","year":"2015","journal-title":"Clin. Infectious Dis.: An Official Publication Infectious Dis. Soc. Am."},{"issue":"10","key":"10.1016\/j.intimp.2022.108870_b0305","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.vaccine.2004.09.006","article-title":"Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls community based case-control study","volume":"23","author":"Stensballe","year":"2005","journal-title":"Vaccine."},{"issue":"1","key":"10.1016\/j.intimp.2022.108870_b0310","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3143\/geriatrics.42.34","article-title":"Sasaki H","volume":"42","author":"Ohrui","year":"2005","journal-title":"Nihon Ronen Igakkai zasshi Japanese J. Geriatrics"},{"issue":"12","key":"10.1016\/j.intimp.2022.108870_b0315","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s10654-020-00698-1","article-title":"Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications","volume":"35","author":"Levin","year":"2020","journal-title":"Eur. J. Epidemiol."},{"issue":"12","key":"10.1016\/j.intimp.2022.108870_b0320","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.cmi.2019.06.002","article-title":"Non-specific effects of BCG in protozoal infections: tegumentary leishmaniasis and malaria","volume":"25","author":"dos Santos","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"issue":"1","key":"10.1016\/j.intimp.2022.108870_b0325","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1128\/iai.16.1.249-257.1977","article-title":"Effect of treatment with BCG on the course of visceral leishmaniasis in BALB\/c mice","volume":"16","author":"Smrkovski","year":"1977","journal-title":"Infect. Immun."},{"issue":"11","key":"10.1016\/j.intimp.2022.108870_b0330","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1007\/s00436-013-3570-5","article-title":"Eimeria maxima: efficacy of recombinant Mycobacterium bovis BCG expressing apical membrane antigen1 against homologous infection","volume":"112","author":"Li","year":"2013","journal-title":"Parasitol. Res."},{"issue":"3","key":"10.1016\/j.intimp.2022.108870_b0335","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3347\/kjp.2014.52.3.251","article-title":"A novel recombinant BCG vaccine encoding eimeria tenella rhomboid and chicken IL-2 induces protective immunity against coccidiosis","volume":"52","author":"Wang","year":"2014","journal-title":"Korean J. Parasitol."},{"issue":"3","key":"10.1016\/j.intimp.2022.108870_b0340","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/dth.12336","article-title":"BCG vaccine for immunotherapy in warts: is it really safe in a tuberculosis endemic area?","volume":"29","author":"Daulatabad","year":"2016","journal-title":"Dermatol. Ther."},{"issue":"2","key":"10.1016\/j.intimp.2022.108870_b0345","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4103\/ijd.IJD_558_16","article-title":"Bacillus Calmette-Guerin Immunotherapy for Recurrent Multiple Warts: An Open-Label Uncontrolled Study","volume":"64","author":"Jaisinghani","year":"2019","journal-title":"Indian J. Dermatol."},{"issue":"4779","key":"10.1016\/j.intimp.2022.108870_b0350","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/190889a0","article-title":"Protective activity of fractions of tubercle bacilli against isologous tumours in mice","volume":"190","author":"Weiss","year":"1961","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2022.108870_b0355","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.coi.2018.09.016","article-title":"Bridging the gap between vaccination with Bacille Calmette-Gu\u00e9rin (BCG) and immunological tolerance: the cases of type 1 diabetes and multiple sclerosis","volume":"55","author":"Ristori","year":"2018","journal-title":"Curr. Opin. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2022.108870_b0360","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/joim.13050","article-title":"Benefits of BCG-induced metabolic switch from oxidative phosphorylation to aerobic glycolysis in autoimmune and nervous system diseases","volume":"288","author":"Faustman","year":"2020","journal-title":"J. Intern. Med."},{"issue":"1","key":"10.1016\/j.intimp.2022.108870_b0365","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-019-0786-3","article-title":"Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination","volume":"7","author":"Tea","year":"2019","journal-title":"Acta Neuropathol Commun."},{"key":"10.1016\/j.intimp.2022.108870_b0370","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1212\/WNL.53.7.1588","article-title":"Use of Bacille Calmette-Gu\u00e8rin (BCG) in multiple sclerosis","volume":"53","author":"Ristori","year":"1999","journal-title":"Neurology."},{"issue":"2","key":"10.1016\/j.intimp.2022.108870_b0375","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4049\/jimmunol.168.2.919","article-title":"Influence of Mycobacterium bovis bacillus Calmette-Gu\u00e9rin on antibody and cytokine responses to human neonatal vaccination","volume":"168","author":"Ota","year":"2002","journal-title":"J. Immunol. (Baltimore, Md: 1950)"},{"key":"10.1016\/j.intimp.2022.108870_b0380","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00029","article-title":"Adjuvant Effect of Bacille Calmette-Gu\u00e9rin on Hepatitis B Vaccine Immunogenicity in the Preterm and Term Newborn","volume":"9","author":"Scheid","year":"2018","journal-title":"Front. Immunol."},{"issue":"30","key":"10.1016\/j.intimp.2022.108870_b0385","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1016\/j.vaccine.2013.03.059","article-title":"Non-specific effect of Bacille Calmette-Gu\u00e9rin vaccine on the immune response to routine immunisations","volume":"31","author":"Ritz","year":"2013","journal-title":"Vaccine."},{"issue":"1","key":"10.1016\/j.intimp.2022.108870_b0390","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-021-00406-4","article-title":"A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection","volume":"6","author":"Counoupas","year":"2021","journal-title":"npj Vaccines"},{"key":"10.1016\/j.intimp.2022.108870_b0395","first-page":"159","article-title":"COVID-19 vaccination clinical trials should consider multiple doses of BCG","volume":"75","author":"Ayoub","year":"2020","journal-title":"Pharmazie"},{"issue":"2","key":"10.1016\/j.intimp.2022.108870_b0400","doi-asserted-by":"crossref","DOI":"10.1128\/mSystems.00297-20","article-title":"Repurposing Didanosine as a Potential Treatment for COVID-19 Using Single-Cell RNA Sequencing Data","volume":"5","author":"Alakwaa","year":"2020","journal-title":"mSystems"},{"key":"10.1016\/j.intimp.2022.108870_b0405","doi-asserted-by":"crossref","first-page":"100036","DOI":"10.1016\/j.medidd.2020.100036","article-title":"Meeting the potential emergency global drug supply challenge of hydroxychloroquine for COVID-19","volume":"5","author":"Zhang","year":"2020","journal-title":"Med Drug Discov."},{"issue":"2","key":"10.1016\/j.intimp.2022.108870_b0410","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/cpt.1857","article-title":"Clinical Pharmacology Perspectives on the Antiviral Activity of Azithromycin and Use in COVID-19","volume":"108","author":"Damle","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.intimp.2022.108870_b0415","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25489","article-title":"Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID-19: initial assessment","volume":"23","author":"Ford","year":"2020","journal-title":"J. Int. AIDS Soc."},{"issue":"1","key":"10.1016\/j.intimp.2022.108870_b0420","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/21645515.2020.1794219","article-title":"Are BCG-induced non-specific effects adequate to provide protection against COVID-19?","volume":"17","author":"Vashishtha","year":"2021","journal-title":"Hum Vaccin Immunother."},{"key":"10.1016\/j.intimp.2022.108870_b0425","doi-asserted-by":"crossref","unstructured":"A. Miller, M.J. Reandelar, K. Fasciglione, V. Roumenova, Y. Li, G.H. Otazu, Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study. medRxiv. 2020:2020.03.24.20042937.","DOI":"10.1101\/2020.03.24.20042937"},{"issue":"4","key":"10.1016\/j.intimp.2022.108870_b0430","first-page":"1371","article-title":"Primary Immunodeficiency Diseases and Bacillus Calmette-Gu\u00e9rin (BCG)-Vaccine-Derived Complications: A Systematic Review. The Journal of Allergy and Clinical Immunology","volume":"8","author":"Fekrvand","year":"2020","journal-title":"In Practice."},{"issue":"32","key":"10.1016\/j.intimp.2022.108870_b0435","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc1463","article-title":"Mandated Bacillus Calmette-Gu\u00e9rin (BCG) vaccination predicts flattened curves for the spread of COVID-19","volume":"6","author":"Berg","year":"2020","journal-title":"Sci. Adv."},{"issue":"30","key":"10.1016\/j.intimp.2022.108870_b0440","doi-asserted-by":"crossref","first-page":"17720","DOI":"10.1073\/pnas.2008410117","article-title":"BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)","volume":"117","author":"Escobar","year":"2020","journal-title":"PNAS"},{"key":"10.1016\/j.intimp.2022.108870_b0445","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3389\/fimmu.2020.00970","article-title":"Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2?","volume":"11","author":"Covi\u00e1n","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2022.108870_b0450","article-title":"Significantly Improved COVID-19 outcomes in countries with higher BCG vaccination coverage: a multivariable analysis","volume":"8","author":"Klinger","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"7","key":"10.1016\/j.intimp.2022.108870_b0455","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/all.14345","article-title":"Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?","volume":"75","author":"Gursel","year":"2020","journal-title":"Allergy"},{"issue":"15","key":"10.1016\/j.intimp.2022.108870_b0460","doi-asserted-by":"crossref","first-page":"5589","DOI":"10.3390\/ijerph17155589","article-title":"BCG Vaccination and Mortality of COVID-19 across 173 Countries: An Ecological Study","volume":"17","author":"Urashima","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.intimp.2022.108870_b0465","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cegh.2020.08.015","article-title":"Is BCG associated with reduced incidence of COVID-19? A meta-regression of global data from 160 countries","volume":"9","author":"Joy","year":"2021","journal-title":"Clinical epidemiology and global health."},{"issue":"1","key":"10.1016\/j.intimp.2022.108870_b0470","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-80787-z","article-title":"The association of Coronavirus Disease-19 mortality and prior bacille Calmette-Guerin vaccination: a robust ecological analysis using unsupervised machine learning","volume":"11","author":"Brooks","year":"2021","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.intimp.2022.108870_b0475","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s15010-020-01566-6","article-title":"Worldwide inverse correlation between Bacille Calmette-Gu\u00e9rin (BCG) immunization and COVID-19 mortality","volume":"49","author":"Li","year":"2021","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.intimp.2022.108870_b0480","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4046\/trd.2020.0063","article-title":"COVID-19 Death and BCG Vaccination Programs Worldwide","volume":"84","author":"Jirjees","year":"2021","journal-title":"Tuberc Respir Dis (Seoul)."},{"issue":"3","key":"10.1016\/j.intimp.2022.108870_b0485","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/jmv.26450","article-title":"Convergence between global BCG vaccination and COVID-19 pandemic","volume":"93","author":"Islam","year":"2021","journal-title":"J. Med. Virol."},{"issue":"2","key":"10.1016\/j.intimp.2022.108870_b0490","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/1757177420976812","article-title":"Association between COVID-19 morbidity and mortality rates and BCG vaccination policies in OECD countries","volume":"22","author":"Senoo","year":"2021","journal-title":"J Infect Prev."},{"issue":"4","key":"10.1016\/j.intimp.2022.108870_b0495","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jinf.2020.08.013","article-title":"Impact of routine infant BCG vaccination on COVID-19","volume":"81","author":"Kinoshita","year":"2020","journal-title":"J. infection."},{"key":"10.1016\/j.intimp.2022.108870_b0500","doi-asserted-by":"crossref","first-page":"e1008969","DOI":"10.1371\/journal.ppat.1008969","article-title":"\u201cTrained immunity\u201d from Mycobacterium spp. exposure or BCG vaccination and COVID-19 outcomes","volume":"16","author":"Singh","year":"2020","journal-title":"PLoS pathogens."},{"key":"10.1016\/j.intimp.2022.108870_b0505","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.puhe.2021.02.018","article-title":"Influence of malaria endemicity and tuberculosis prevalence on COVID-19 mortality","volume":"194","author":"Raham","year":"2021","journal-title":"Public Health"},{"key":"10.1016\/j.intimp.2022.108870_b0510","article-title":"Epidemiological Differences of COVID-19 Over the World","volume":"12","author":"Sayed","year":"2020","journal-title":"Cureus."},{"issue":"6","key":"10.1016\/j.intimp.2022.108870_b0515","doi-asserted-by":"crossref","first-page":"e0253169","DOI":"10.1371\/journal.pone.0253169","article-title":"Association of the past epidemic of Mycobacterium tuberculosis with mortality and incidence of COVID-19","volume":"16","author":"Inoue","year":"2021","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.intimp.2022.108870_b0520","doi-asserted-by":"crossref","first-page":"727","DOI":"10.4103\/ijcm.IJCM_103_21","article-title":"Association of Bacillus Calmette Guerin Vaccine Strains with COVID-19 Morbidity and Mortality - Evaluation of Global Data","volume":"46","author":"Chaudhari","year":"2021","journal-title":"Indian J. Community Med."},{"issue":"10","key":"10.1016\/j.intimp.2022.108870_b0525","doi-asserted-by":"crossref","first-page":"e0240710","DOI":"10.1371\/journal.pone.0240710","article-title":"Global impact of environmental temperature and BCG vaccination coverage on the transmissibility and fatality rate of COVID-19","volume":"15","author":"Kumar","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2022.108870_b0530","article-title":"Exploration of Association Between Respiratory Vaccinations With Infection and Mortality Rates of COVID-19","volume":"1\u201316","author":"Abdulah","year":"2021","journal-title":"Disaster Med Public Health Prep."},{"issue":"9","key":"10.1016\/j.intimp.2022.108870_b0535","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1080\/21645515.2021.1908058","article-title":"Countries with high deaths due to flu and tuberculosis demonstrate lower COVID-19 mortality: roles of vaccinations","volume":"17","author":"Pathak","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.intimp.2022.108870_b0540","first-page":"501","article-title":"Bacillus Calmette-Guerin vaccination Policy and Consumption of Ammonium Chloride-Enriched Confectioneries May Be Factors Reducing COVID-19 Death Rates in Europe","volume":"22","author":"Hidv\u00e9gi","year":"2020","journal-title":"Isr Med. Assoc. J."},{"issue":"2","key":"10.1016\/j.intimp.2022.108870_b0545","doi-asserted-by":"crossref","first-page":"179","DOI":"10.7774\/cevr.2020.9.2.179","article-title":"Current national policies for infant universal bacille Calmette-Gu\u00e9rin vaccination were associated with lower mortality from coronavirus disease 2019","volume":"9","author":"Ebina-Shibuya","year":"2020","journal-title":"Clin. Exp. Vaccine Res."},{"issue":"10","key":"10.1016\/j.intimp.2022.108870_b0550","doi-asserted-by":"crossref","first-page":"e0240203","DOI":"10.1371\/journal.pone.0240203","article-title":"BCG epidemiology supports its protection against COVID-19?","volume":"15","author":"Szigeti","year":"2020","journal-title":"A word of caution. PloS one."},{"key":"10.1016\/j.intimp.2022.108870_b0555","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268821000571","article-title":"Association between live childhood vaccines and COVID-19 outcomes: a national-level analysis","volume":"149","author":"Ogimi","year":"2021","journal-title":"Epidemiol. Infect."},{"issue":"6","key":"10.1016\/j.intimp.2022.108870_b0560","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/joim.13198","article-title":"On the relationship between BCG coverage and national COVID-19 outcome: could 'heterologous' herd immunity explain why some countries are better off?","volume":"288","author":"Lerm","year":"2020","journal-title":"J. Intern. Med."},{"issue":"8","key":"10.1016\/j.intimp.2022.108870_b0565","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1038\/s41375-020-0871-4","article-title":"Regional BCG vaccination policy in former East- and West Germany may impact on both severity of SARS-CoV-2 and incidence of childhood leukemia","volume":"34","author":"Hauer","year":"2020","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.intimp.2022.108870_b0570","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.vaccine.2020.12.026","article-title":"BCG vaccine: Worrying proposal for COVID-19","volume":"39","author":"Sarinho","year":"2021","journal-title":"Vaccine."},{"key":"10.1016\/j.intimp.2022.108870_b0575","doi-asserted-by":"crossref","unstructured":"Meena J, Yadav A, Kumar J. BCG Vaccination Policy and Protection Against COVID-19. Indian J. Pediatrics 2020;87:749.","DOI":"10.1007\/s12098-020-03371-3"},{"issue":"41","key":"10.1016\/j.intimp.2022.108870_b0580","doi-asserted-by":"crossref","first-page":"25203","DOI":"10.1073\/pnas.2016733117","article-title":"Lack of evidence for BCG vaccine protection from severe COVID-19","volume":"117","author":"Lindestam Arlehamn","year":"2020","journal-title":"PNAS"},{"issue":"8","key":"10.1016\/j.intimp.2022.108870_b0585","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.3390\/ijerph18084303","article-title":"COVID-19 Severity and Neonatal BCG Vaccination among Young Population in Taiwan","volume":"18","author":"Su","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.intimp.2022.108870_b0590","doi-asserted-by":"crossref","first-page":"18377","DOI":"10.1038\/s41598-020-75491-x","article-title":"Protection against SARS-CoV-2 by BCG vaccination is not supported by epidemiological analyses","volume":"10","author":"Hensel","year":"2020","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.intimp.2022.108870_b0595","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/lam.13365","article-title":"BCG vaccination early in life does not improve COVID-19 outcome of elderly populations, based on nationally reported data","volume":"71","author":"Wassenaar","year":"2020","journal-title":"Lett. Appl. Microbiol."},{"issue":"12","key":"10.1016\/j.intimp.2022.108870_b0600","doi-asserted-by":"crossref","first-page":"e0243707","DOI":"10.1371\/journal.pone.0243707","article-title":"An ecological study to evaluate the association of Bacillus Calmette-Guerin (BCG) vaccination on cases of SARS-CoV2 infection and mortality from COVID-19","volume":"15","author":"Chimoyi","year":"2020","journal-title":"PLoS ONE"},{"issue":"22","key":"10.1016\/j.intimp.2022.108870_b0605","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1001\/jama.2020.8189","article-title":"SARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults","volume":"323","author":"Hamiel","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2022.108870_b0610","doi-asserted-by":"crossref","unstructured":"de Chaisemartin C, de Chaisemartin L. Bacille Calmette-Gu\u00e9rin Vaccination in Infancy Does Not Protect Against Coronavirus Disease 2019 (COVID-19): Evidence From a Natural Experiment in Sweden. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2021;72:e501-e5.","DOI":"10.1093\/cid\/ciaa1223"},{"key":"10.1016\/j.intimp.2022.108870_b0615","doi-asserted-by":"crossref","first-page":"646570","DOI":"10.3389\/fphar.2021.646570","article-title":"A Survey Among Italian Physicians During COVID-19 Outbreak Could Bacillus Calmette-Gu\u00e9rin Vaccine Be Effective Against SARS-CoV2?","volume":"12","author":"Patella","year":"2021","journal-title":"Front Pharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2022.108870_b0620","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4103\/ijmy.ijmy_179_21","article-title":"Exploring the role of bacillus calmette-guerin vaccination in protection against COVID-19","volume":"10","author":"Chauhan","year":"2021","journal-title":"Int. J. Mycobacteriol."},{"issue":"7","key":"10.1016\/j.intimp.2022.108870_b0625","doi-asserted-by":"crossref","first-page":"e0009635","DOI":"10.1371\/journal.pntd.0009635","article-title":"The influence of leprosy-related clinical and epidemiological variables in the occurrence and severity of COVID-19: A prospective real-world cohort study","volume":"15","author":"Cerqueira","year":"2021","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.intimp.2022.108870_b0630","first-page":"1","article-title":"BCG vaccination at birth and COVID-19: a case-control study among U.S. military Veterans","author":"Bates","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.intimp.2022.108870_b0635","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268820001569","article-title":"Bacillus Calmette-Gu\u00e9rin vaccination and clinical characteristics and outcomes of COVID-19 in Rhode Island, United States: a cohort study","volume":"148","author":"Weng","year":"2020","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.intimp.2022.108870_b0640","doi-asserted-by":"crossref","unstructured":"Aksu K, Lu TBN, Zkan P. Factors determining COVID-19 pneumonia severity in a country with routine BCG vaccination. 2020.","DOI":"10.22541\/au.159466929.97258741"},{"key":"10.1016\/j.intimp.2022.108870_b0645","series-title":"Oxford Martin Programme on Global Development O. Policy Responses to the Coronavirus Pandemic","year":"2022"},{"issue":"8","key":"10.1016\/j.intimp.2022.108870_b0650","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1080\/21645515.2021.1872344","article-title":"Anticipated reduction in COVID-19 mortality due to population-wide BCG vaccination: evidence from Germany","volume":"17","author":"Mar\u00edn-Hern\u00e1ndez","year":"2021","journal-title":"Hum Vaccin Immunother."},{"issue":"2","key":"10.1016\/j.intimp.2022.108870_b0655","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000355628","article-title":"Long-lasting effects of BCG vaccination on both heterologous Th1\/Th17 responses and innate trained immunity","volume":"6","author":"Kleinnijenhuis","year":"2014","journal-title":"J. Innate Immun."},{"issue":"2","key":"10.1016\/j.intimp.2022.108870_b0660","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1473-3099(15)00400-4","article-title":"Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study","volume":"16","author":"Nguipdop-Djomo","year":"2016","journal-title":"Lancet. Infect. Dis"},{"issue":"50","key":"10.1016\/j.intimp.2022.108870_b0665","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1016\/j.vaccine.2021.08.019","article-title":"Does BCG provide long-term protection against SARS-CoV-2 infection? A case-control study in Quebec","volume":"39","author":"P\u00e9pin","year":"2021","journal-title":"Canada. Vaccine."},{"issue":"5","key":"10.1016\/j.intimp.2022.108870_b0670","doi-asserted-by":"crossref","first-page":"100073","DOI":"10.1016\/j.xcrm.2020.100073","article-title":"Safety and COVID-19 Symptoms in Individuals Recently Vaccinated with BCG: a Retrospective Cohort Study","volume":"1","author":"Moorlag","year":"2020","journal-title":"Cell reports Medicine."},{"key":"10.1016\/j.intimp.2022.108870_b0675","doi-asserted-by":"crossref","DOI":"10.1172\/JCI145157","article-title":"BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of health care workers","volume":"131","author":"Rivas","year":"2021","journal-title":"J. Clin. Investigation"},{"issue":"3","key":"10.1016\/j.intimp.2022.108870_b0680","doi-asserted-by":"crossref","first-page":"276","DOI":"10.7774\/cevr.2021.10.3.276","article-title":"Severity of COVID-19 in bacillus Calmette-Gu\u00e9rin vaccinated population","volume":"10","author":"Khanum","year":"2021","journal-title":"Clin. Exp. Vaccine Res."},{"issue":"2","key":"10.1016\/j.intimp.2022.108870_b0685","doi-asserted-by":"crossref","first-page":"191","DOI":"10.7774\/cevr.2021.10.2.191","article-title":"A possible protective role for Bacillus Calmette-Gu\u00e9rin therapy in urinary bladder cancer in the era of COVID-19: a brief report","volume":"10","author":"Ohadian Moghadam","year":"2021","journal-title":"Clin. Exp. Vaccine Res."},{"issue":"suppl 2","key":"10.1016\/j.intimp.2022.108870_b0690","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1590\/1806-9282.66.s2.91","article-title":"Investigation of the frequency of COVID-19 in patients treated with intravesical BCG","volume":"66","author":"Karabay","year":"1992","journal-title":"Rev. Assoc. Med. Bras."},{"issue":"2","key":"10.1016\/j.intimp.2022.108870_b0695","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1080\/21645515.2020.1805994","article-title":"Intravescical instillation of Calmette-Gu\u00e9rin bacillus and COVID-19 risk","volume":"17","author":"Fedeli","year":"2021","journal-title":"Hum Vaccin Immunother."},{"key":"10.1016\/j.intimp.2022.108870_b0700","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12894-021-00823-6","article-title":"Protective role of intravesical BCG in COVID-19 severity","volume":"21","author":"Gallegos","year":"2021","journal-title":"BMC Urol."},{"key":"10.1016\/j.intimp.2022.108870_b0705","first-page":"98","article-title":"BCG vaccination induces enhanced frequencies of dendritic cells and altered plasma levels of type I and type III interferons in elderly individuals","volume":"110","author":"Kumar","year":"2021","journal-title":"Int. J. Infectious Dis.: IJID: Official Publication Int. Soc. Infect. Dis."},{"key":"10.1016\/j.intimp.2022.108870_b0710","doi-asserted-by":"crossref","unstructured":"M. Tsilika, E. Taks, K. Dolianitis, A. Kotsaki, K. Leventogiannis, C. Damoulari et al. ACTIVATE-2: a double-blind randomized trial of BCG vaccination against COVID-19 in individuals at risk. medRxiv. 2021:2021.05.20.21257520.","DOI":"10.1101\/2021.05.20.21257520"},{"issue":"11","key":"10.1016\/j.intimp.2022.108870_b0715","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1080\/21645515.2021.1956228","article-title":"Effectiveness of booster BCG vaccination in preventing Covid-19 infection","volume":"17","author":"Amirlak","year":"2021","journal-title":"Hum. Vaccin Immunother."},{"key":"10.1016\/j.intimp.2022.108870_b0720","doi-asserted-by":"crossref","unstructured":"U. Padmanabhan, S. Mukherjee, R. Borse, S. Joshi, R. Deshmukh, Phase II Clinical trial for Evaluation of BCG as potential therapy for COVID-19. medRxiv. 2020:2020.10.28.20221630.","DOI":"10.1101\/2020.10.28.20221630"},{"issue":"11","key":"10.1016\/j.intimp.2022.108870_b0725","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.3390\/cells10113179","article-title":"Effect of BCG Revaccination on Occupationally Exposed Medical Personnel Vaccinated against SARS-CoV-2","volume":"10","author":"Ramos-Martinez","year":"2021","journal-title":"Cells."},{"issue":"2","key":"10.1016\/j.intimp.2022.108870_b0730","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3390\/vaccines10020314","volume":"10","author":"Czajka","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"10.1016\/j.intimp.2022.108870_b0735","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211862","article-title":"Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge","volume":"219","author":"Hilligan","year":"2022","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.intimp.2022.108870_b0740","doi-asserted-by":"crossref","first-page":"e1010093","DOI":"10.1371\/journal.ppat.1010093","article-title":"Mice infected with Mycobacterium tuberculosis are resistant to acute disease caused by secondary infection with SARS-CoV-2","volume":"18","author":"Rosas Mejia","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.intimp.2022.108870_b0745","doi-asserted-by":"crossref","first-page":"801799","DOI":"10.3389\/fimmu.2021.801799","article-title":"Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques","volume":"12","author":"White","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2022.108870_b0750","doi-asserted-by":"crossref","first-page":"e2000200","DOI":"10.1002\/bies.202000200","article-title":"Can BCG vaccine protect against COVID-19 via trained immunity and tolerogenesis?","volume":"43","author":"Basak","year":"2021","journal-title":"BioEssays"},{"key":"10.1016\/j.intimp.2022.108870_b0755","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1172\/JCI141317","article-title":"Antituberculosis BCG vaccination: more reasons for varying innate and adaptive immune responses","volume":"130","author":"Prentice","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.intimp.2022.108870_b0760","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nri.2016.43","article-title":"Harnessing the beneficial heterologous effects of vaccination","volume":"16","author":"Goodridge","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2022.108870_b0765","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.it.2013.04.004","article-title":"A small jab - a big effect: nonspecific immunomodulation by vaccines","volume":"34","author":"Benn","year":"2013","journal-title":"Trends Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2022.108870_b0770","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1128\/JVI.02393-08","article-title":"CD4 T-cell-mediated heterologous immunity between mycobacteria and poxviruses","volume":"83","author":"Mathurin","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2022.108870_b0775","doi-asserted-by":"crossref","first-page":"692729","DOI":"10.3389\/fimmu.2021.692729","article-title":"BCG Vaccine Derived Peptides Induce SARS-CoV-2 T Cell Cross-Reactivity","volume":"12","author":"Eggenhuizen","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2022.108870_b0780","doi-asserted-by":"crossref","first-page":"812176","DOI":"10.3389\/fimmu.2021.812176","article-title":"Large-Scale Structure-Based Screening of Potential T Cell Cross-Reactivities Involving Peptide-Targets From BCG Vaccine and SARS-CoV-2","volume":"12","author":"Tarabini","year":"2021","journal-title":"Front. Immunol."},{"issue":"41","key":"10.1016\/j.intimp.2022.108870_b0785","doi-asserted-by":"crossref","first-page":"6352","DOI":"10.1016\/j.vaccine.2020.08.045","article-title":"BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis","volume":"38","author":"Tomita","year":"2020","journal-title":"Vaccine."},{"issue":"1","key":"10.1016\/j.intimp.2022.108870_b0790","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s12192-021-01244-y","article-title":"Sequence similarity of HSP65 of Mycobacterium bovis BCG with SARS-CoV-2 spike and nuclear proteins: may it predict an antigen-dependent immune protection of BCG against COVID-19?","volume":"27","author":"Finotti","year":"2022","journal-title":"Cell Stress Chaperones."},{"key":"10.1016\/j.intimp.2022.108870_b0795","doi-asserted-by":"crossref","first-page":"151600","DOI":"10.1016\/j.anndiagpath.2020.151600","article-title":"Strong homology between SARS-CoV-2 envelope protein and a Mycobacterium sp. antigen allows rapid diagnosis of Mycobacterial infections and may provide specific anti-SARS-CoV-2 immunity via the BCG vaccine","volume":"48","author":"Nuovo","year":"2020","journal-title":"Ann. Diagnostic Pathol."},{"issue":"1","key":"10.1016\/j.intimp.2022.108870_b0800","doi-asserted-by":"crossref","DOI":"10.1186\/s12859-021-04045-3","article-title":"In silico comparative study of SARS-CoV-2 proteins and antigenic proteins in BCG, OPV, MMR and other vaccines: evidence of a possible putative protective effect","volume":"22","author":"Haddad-Boubaker","year":"2021","journal-title":"BMC Bioinf."},{"issue":"12","key":"10.1016\/j.intimp.2022.108870_b0805","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1227","article-title":"Identification of similar epitopes between severe acute respiratory syndrome coronavirus-2 and Bacillus Calmette-Gu\u00e9rin: potential for cross-reactive adaptive immunity","volume":"9","author":"Urb\u00e1n","year":"2020","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.intimp.2022.108870_b0810","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1084\/jem.20031051","article-title":"Memory CD8+ T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen","volume":"198","author":"Berg","year":"2003","journal-title":"J. Exp. Med."},{"issue":"6284","key":"10.1016\/j.intimp.2022.108870_b0815","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: A program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.intimp.2022.108870_b0820","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"PNAS"},{"issue":"10","key":"10.1016\/j.intimp.2022.108870_b0825","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2217\/fmb-2018-0026","article-title":"Heterologous effects of infant BCG vaccination: potential mechanisms of immunity","volume":"13","author":"Butkeviciute","year":"2018","journal-title":"Future Microbiol."},{"key":"10.1016\/j.intimp.2022.108870_b0830","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.smim.2018.06.002","article-title":"Non-specific effects of vaccines: Current evidence and potential implications","volume":"39","author":"de Bree","year":"2018","journal-title":"Semin. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2022.108870_b0835","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1080\/21645515.2020.1818522","article-title":"BCG vaccine: a hope to control COVID-19 pandemic amid crisis","volume":"16","author":"Malik","year":"2020","journal-title":"Hum. Vaccin Immunother."},{"issue":"5","key":"10.1016\/j.intimp.2022.108870_b0840","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s10875-010-9431-4","article-title":"Inflammasomes and anti-viral immunity","volume":"30","author":"Rathinam","year":"2010","journal-title":"J. Clin. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2022.108870_b0845","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Del Valle","year":"2020","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.intimp.2022.108870_b0850","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-021-00881-3","article-title":"IFN-\u03b3 and TNF-\u03b1 drive a CXCL10+ CCL2+ macrophage phenotype expanded in severe COVID-19 lungs and inflammatory diseases with tissue inflammation","volume":"13","author":"Zhang","year":"2021","journal-title":"Genome Med."},{"issue":"7","key":"10.1016\/j.intimp.2022.108870_b0855","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.cell.2021.02.029","article-title":"COVID-19 and the human innate immune system","volume":"184","author":"Schultze","year":"2021","journal-title":"Cell"},{"issue":"32","key":"10.1016\/j.intimp.2022.108870_b0860","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg7181","article-title":"Effect of BCG vaccination on proinflammatory responses in elderly individuals","volume":"7","author":"Pavan Kumar","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.intimp.2022.108870_b0865","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1172\/JCI133935","article-title":"BCG vaccination in humans inhibits systemic inflammation in a sex-dependent manner","volume":"130","author":"Koeken","year":"2020","journal-title":"J. Clin Invest."},{"issue":"48","key":"10.1016\/j.intimp.2022.108870_b0870","doi-asserted-by":"crossref","first-page":"7629","DOI":"10.1016\/j.vaccine.2020.10.009","article-title":"Bacillus Calmette-Gu\u00e9rin (BCG) vaccine generates immunoregulatory cells in the cervical lymph nodes in guinea pigs injected intra dermally","volume":"38","author":"Vergkizi","year":"2020","journal-title":"Vaccine."},{"issue":"7","key":"10.1016\/j.intimp.2022.108870_b0875","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1080\/14760584.2017.1333906","article-title":"BCG and protection against inflammatory and auto-immune diseases","volume":"16","author":"Kowalewicz-Kulbat","year":"2017","journal-title":"Expert Rev Vaccines."},{"key":"10.1016\/j.intimp.2022.108870_b0880","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1399-3038.2010.01051.x","article-title":"Neonatal BCG vaccination induces IL-10 production by CD4+ CD25+ T cells","volume":"21","author":"Akkoc","year":"2010","journal-title":"Pediatr. Allergy Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2022.108870_b0885","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1002\/eji.201243286","article-title":"CD39 is involved in mediating suppression by Mycobacterium bovis BCG-activated human CD8(+) CD39(+) regulatory T cells","volume":"43","author":"Boer","year":"2013","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.108870_b0890","doi-asserted-by":"crossref","DOI":"10.1038\/srep24193","article-title":"Mycobacteria-responsive sonic hedgehog signaling mediates programmed death-ligand 1- and prostaglandin E2-induced regulatory T cell expansion","volume":"6","author":"Holla","year":"2016","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.intimp.2022.108870_b0895","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/ni.3269","article-title":"Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants","volume":"16","author":"De Rosa","year":"2015","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2022.108870_b0900","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.immuni.2016.01.028","article-title":"The Proteomic Landscape of Human Ex Vivo Regulatory and Conventional T Cells Reveals Specific Metabolic Requirements","volume":"44","author":"Procaccini","year":"2016","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.intimp.2022.108870_b0905","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/22221751.2021.1898291","article-title":"Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic","volume":"10","author":"To","year":"2021","journal-title":"Emerg Microbes Infect."},{"key":"10.1016\/j.intimp.2022.108870_b0910","doi-asserted-by":"crossref","unstructured":"N. Hupert, D. Mar\u00edn-Hern\u00e1ndez, B. Gao, R. \u00c1guas, D.F. Nixon, Heterologous vaccination interventions to reduce pandemic morbidity and mortality: Modeling the US winter 2020 COVID-19 wave, in: Proceedings of the National Academy of Sciences of the United States of America. 2022;119.","DOI":"10.1073\/pnas.2025448119"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692200354X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692200354X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:53:17Z","timestamp":1761587597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692200354X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":182,"alternative-id":["S156757692200354X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.108870","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BCG Vaccination: A potential tool against COVID-19 and COVID-19-like Black Swan incidents","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.108870","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108870"}}